Graham Reynolds, Global Biologics, looks at the advantages of polymer containers over glass in biologic drug delivery
Glass Ceiling
For drug manufacturers one of the early considerations for any container system is likely to be the interaction between the drug and the container closure system. Many companies evaluate both a glass and plastic option at an early stage of the development process to ensure that they have an appropriate solution that may help to optimise time to market and ultimate effectiveness and quality of the product. As part of compatibility testing, interaction with any materials that might be present in the system are examined.